Northwest Biotherapeutics

Latest Headlines

Latest Headlines

Northwest Bio says it is running out of cash

Northwest Biotherapeutics startled investors with the news that it has only $1.1 million of cash on hand--enough to fund operations through September. And assurances that the developer is in talks

Researchers explore brain cancer vaccine

Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from